Extensive adoption of nanomedicine in drug and delivery systems due to rising technological advancement is driving nanomedicine market revenue growth
Extensive adoption of nanomedicine in drug and delivery systems due to rising technological advancement is driving nanomedicine market revenue growth
The global nanomedicine market size is expected to reach USD 779.99 Billion in 2030 and register a revenue CAGR of 13.6% during the forecast period. Rising prevalence of cancer and genetic and cardiovascular diseases, increasing advancements in nanoscale technologies for diagnostic and treatment procedures, and growing preference for personalized medicine are driving nanomedicine market revenue growth.
Nanotechnology is effective in tissue regeneration for recreating nanoscale features of tissues that can direct cellular adhesion, migration, and differentiation. In addition, nanomedicine can treat bone, muscle, cardiovascular, and neural tissue diseases.
Nanomedicine is composed of nanoscale materials such as biocompatible nanoparticles and nanorobots, which can effectively control, prevent, monitor, treat, and diagnose diseases. Nanomedicine plays a vital role in development of advanced and innovative drugs due to its revolutionary small size, and is designed to offer better results and reduce side effects of standard therapies, such as chemotherapy and radiation therapy. Nanomedicine can also be designed to help immune cells and subsequently eliminate or decrease the number of infected cells in the body.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1048
Nanomedicine can help in the treatment of cancer, owing to its ability to improve anticancer immunity and efficacy of immunotherapy. According to World Health Organization (WHO), in 2020, nearly 10 million people died of cancer worldwide, making it one of the leading causes of death across the world. Since nanomedicine has the potential to treat cancer, investment in the nanomedicine market has been exponential in recent times.
Increasing prevalence of genetic and infectious diseases is one of the major growth-driving factors for the global nanomedicine market. Nanomedicine is an emerging area that uses nanoparticles for drug delivery, diagnosis, and in vivo imaging, and helps to improve various issues related to human health. It offers solutions for various chronic diseases, such as Alzheimer’s disease, diabetes, cancer, and others. However, high cost of nanoparticle-assisted medicine as compared to its traditional counterparts, and stringent regulatory issues are hampering growth of the market.
Some Key Highlights from the Report
- In September 2020, Clene Nanomedicine Inc., a U.S.-based company involved in developing potential therapeutic nanocatalyst for the treatment of neurodegenerative diseases with antiviral applications, announced a merger with Tottenham Acquisition I Limited. The merger will advance Clene’s CNM-Au8 into Phase 2 and 3 clinical studies. CNM-Au8 is aimed at developing treatment for neurogenetic diseases such as Parkinson’s disease.
- Nanoparticles segment accounted for largest revenue share in 2020. Cancer cell can be identified and treated with the help of nanoparticles, and they also allow detection of diseases in early stages.
- Therapeutics segment accounted for a significantly large revenue share in 2020 and is expected to register a rapid revenue growth rate during the forecast period. Therapeutics is a rapidly advancing field of nanomedicine that brings together tissue engineering, transplantation, cell biology, and regeneration.
- Oncology segment accounted for largest revenue share in 2020 and is expected to register a rapid revenue growth rate during the forecast period, as nanomedicine is increasingly used in cancer treatment. Nanomedicine helps in the creation of highly efficient cancer medicines with fewer side effects.
- Diagnostic segment accounted for a significantly large revenue share in 2020. Nanoscale particles increase the sensitivity, speed, and flexibility of biological tests by measuring the presence or activity of substances. Nanotechnology also enables testing of relatively smaller volume samples, which is expected to increase its application and boost growth of the segment during the forecast period.
- Market in North America accounted for largest revenue share in 2020. The region has rapidly adopted nanotechnology and is investing heavily in newer technologies such as artificial intelligence, biotechnology, and others, for the advancement of the healthcare sector. Nanomedicine can detect life-threatening diseases in early stages and help in collecting real-time information from patients, which can assist in providing life-saving medical treatment. Increasing adoption of nanomedicine for the treatment of cancer and various other infectious diseases is increasing demand for advanced technologies, which is boosting growth of the market in North America.
- Companies profiled in the global market report include Abbott, General Electric (GE), Arrowhead Pharmaceuticals, Brigham and Women’s Hospital, Nanospectra Biosciences, AMAG Pharmaceuticals, Celgene Corporation, Leadiant Biosciences, Inc., Pfizer Inc., and Sanofi.
Get In detailed Research Study @ https://www.reportsanddata.com/report-detail/nanomedicine-market
For this report, Reports and Data has segmented the global nanomedicine market based on nanomolecule type, product type, application, modality, and region:
Nanomolecule Type Outlook (Revenue, USD Billion; 2018–2030)
- Nanoparticles
- Nanoshells
- Nanotubes
- Nanodevices
- Others
Product Type Outlook (Revenue, USD Billion; 2018–2030)
- Therapeutics
- Regenerative Medicine
- In-Vitro Diagnostics
- Vaccines
- Others
Application Outlook (Revenue, USD Billion; 2018–2030)
- Drug Delivery
- Diagnostic Imaging
- Tissue Regeneration
- Biomaterials
- Oncology
- Others
Modality Outlook (Revenue, USD Billion; 2018–2030)
- Diagnostic
- Treatment
Download Summary @ https://www.reportsanddata.com/download-summary-form/1048
Regional Outlook (Revenue, USD Billion; 2018–2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of MEA
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/1048
Some points on how the report benefits stakeholders:
- The reports include historical (2019–2020) and forecast (2021–2030) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2019 and 2030.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Cannabis Concentrate Market , By Type (Shatter, Wax, Badder/Budder, Live Resin, Tincture of cannabis, Hashish/Hash, Bubble Hash, Charas, Crumble, Crystalline, Oil, Rosin, Others), By Consumption Method (Smoking Methods, Dabbing, Pre-Filled Vape Pens, Handheld Vaporizers, Cannabis Tinctures, Others), By End Use (Pharmaceuticals, Food Industry, Recreational), and By Region Forecast to 2028
Connected Health Device Market , By Product Type (Connected Health Personal Medical Devices, Connected Health Wellness Devices), By End-Use (Hospitals/Clinic, Home Monitoring), and By Region Forecast to 2028
Wax Therapy Market Size, Share And Industry Analysis By Product Type (Fixed Therapy Bath And Portable Therapy Bath), By Application (Osteoarthritis, Rheumatoid Arthritis, Fibromyalgia, Joint Mobility Issues, Scleroderma, and Raynaud\'s Or Any Rheumatic Pains), By End-Use, and By Region Forecast To 2028
Tangential Flow Filtration Market Size, Share And Industry Analysis By Product Type (TFF System and Membrane Filter), By Technique (Ultrafiltration and Microfiltration), By Material Type (PES/PS Membrane and Regenerated Cellulose), By Application (Bioprocess, Viral Vector Purification, and Others), By End-Use, and By Region Forecast to 2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-nanomedicine-market